Erratum: Paradox-Breaking RAF Inhibitors that Also Target SRC Are Effective in Drug-Resistant BRAF Mutant Melanoma (Cancer Cell (2015) 27(1) (85–96) (S1535610814004577) (10.1016/j.ccell.2014.11.006))

Maria Romina Girotti; Filipa Lopes; Natasha Preece; Dan Niculescu-Duvaz; Alfonso Zambon; Lawrence Davies; Steven Whittaker; Grazia Saturno; Amaya Viros; Malin Pedersen; Bart M.J.M. Suijkerbuijk; Delphine Menard; Robert McLeary; Louise Johnson; Laura Fish; Sarah Ejiama; Berta Sanchez-Laorden; Juliane Hohloch; Neil Carragher; Kenneth Macleod; Garry Ashton; Anna A. Marusiak; Alberto Fusi; John Brognard; Margaret Frame; Paul Lorigan; Richard Marais; Caroline Springer

doi:10.1016/j.ccell.2017.02.007

Erratum: Paradox-Breaking RAF Inhibitors that Also Target SRC Are Effective in Drug-Resistant BRAF Mutant Melanoma (Cancer Cell (2015) 27(1) (85–96) (S1535610814004577) (10.1016/j.ccell.2014.11.006))

Maria Romina Girotti, Filipa Lopes, Natasha Preece, Dan Niculescu-Duvaz, Alfonso Zambon, Lawrence Davies, Steven Whittaker, Grazia Saturno, Amaya Viros, Malin Pedersen, Bart M.J.M. Suijkerbuijk, Delphine Menard, Robert McLeary, Louise Johnson, Laura Fish, Sarah Ejiama, Berta Sanchez-Laorden, Juliane Hohloch, Neil Carragher, Kenneth MacleodGarry Ashton, Anna A. Marusiak, Alberto Fusi, John Brognard, Margaret Frame, Paul Lorigan, Richard Marais^*, Caroline Springer

^*Corresponding author for this work

Research output: Contribution to journal › Commentary/debate › peer-review

Abstract

(Cancer Cell 27, 85–96, January 12, 2015) The authors have noted an error in Figure 6A of the originally published version of this article. The image for pERK (top right panel) was incorrectly duplicated from Figure 4E (top right panel). The corrected Figure 6 is shown here. This error does not alter the original conclusions of the study, but the authors wish to apologize for this oversight and any confusion that may have resulted.

Original language	English
Number of pages	1
Journal	Cancer Cell
Volume	31
Issue number	3
DOIs	https://doi.org/10.1016/j.ccell.2017.02.007
Publication status	Published - 13 Mar 2017

Research Beacons, Institutes and Platforms

Manchester Cancer Research Centre

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ccell.2017.02.007

Cite this

Girotti, M. R., Lopes, F., Preece, N., Niculescu-Duvaz, D., Zambon, A., Davies, L., Whittaker, S., Saturno, G., Viros, A., Pedersen, M., Suijkerbuijk, B. M. J. M., Menard, D., McLeary, R., Johnson, L., Fish, L., Ejiama, S., Sanchez-Laorden, B., Hohloch, J., Carragher, N., ... Springer, C. (2017). Erratum: Paradox-Breaking RAF Inhibitors that Also Target SRC Are Effective in Drug-Resistant BRAF Mutant Melanoma (Cancer Cell (2015) 27(1) (85–96) (S1535610814004577) (10.1016/j.ccell.2014.11.006)). Cancer Cell, 31(3). https://doi.org/10.1016/j.ccell.2017.02.007

@article{4b4092f90a644213a106d61b2fc2be76,

title = "Erratum: Paradox-Breaking RAF Inhibitors that Also Target SRC Are Effective in Drug-Resistant BRAF Mutant Melanoma (Cancer Cell (2015) 27(1) (85–96) (S1535610814004577) (10.1016/j.ccell.2014.11.006))",

abstract = "(Cancer Cell 27, 85–96, January 12, 2015) The authors have noted an error in Figure 6A of the originally published version of this article. The image for pERK (top right panel) was incorrectly duplicated from Figure 4E (top right panel). The corrected Figure 6 is shown here. This error does not alter the original conclusions of the study, but the authors wish to apologize for this oversight and any confusion that may have resulted.",

author = "Girotti, {Maria Romina} and Filipa Lopes and Natasha Preece and Dan Niculescu-Duvaz and Alfonso Zambon and Lawrence Davies and Steven Whittaker and Grazia Saturno and Amaya Viros and Malin Pedersen and Suijkerbuijk, {Bart M.J.M.} and Delphine Menard and Robert McLeary and Louise Johnson and Laura Fish and Sarah Ejiama and Berta Sanchez-Laorden and Juliane Hohloch and Neil Carragher and Kenneth Macleod and Garry Ashton and Marusiak, {Anna A.} and Alberto Fusi and John Brognard and Margaret Frame and Paul Lorigan and Richard Marais and Caroline Springer",

year = "2017",

month = mar,

day = "13",

doi = "10.1016/j.ccell.2017.02.007",

language = "English",

volume = "31",

journal = "Cancer Cell",

issn = "1535-6108",

publisher = "Cell Press",

number = "3",

}

Girotti, MR, Lopes, F, Preece, N, Niculescu-Duvaz, D, Zambon, A, Davies, L, Whittaker, S, Saturno, G, Viros, A, Pedersen, M, Suijkerbuijk, BMJM, Menard, D, McLeary, R, Johnson, L, Fish, L, Ejiama, S, Sanchez-Laorden, B, Hohloch, J, Carragher, N, Macleod, K, Ashton, G, Marusiak, AA, Fusi, A, Brognard, J, Frame, M, Lorigan, P, Marais, R & Springer, C 2017, 'Erratum: Paradox-Breaking RAF Inhibitors that Also Target SRC Are Effective in Drug-Resistant BRAF Mutant Melanoma (Cancer Cell (2015) 27(1) (85–96) (S1535610814004577) (10.1016/j.ccell.2014.11.006))', Cancer Cell, vol. 31, no. 3. https://doi.org/10.1016/j.ccell.2017.02.007

Erratum: Paradox-Breaking RAF Inhibitors that Also Target SRC Are Effective in Drug-Resistant BRAF Mutant Melanoma (Cancer Cell (2015) 27(1) (85–96) (S1535610814004577) (10.1016/j.ccell.2014.11.006)). / Girotti, Maria Romina; Lopes, Filipa; Preece, Natasha et al.
In: Cancer Cell, Vol. 31, No. 3, 13.03.2017.

Research output: Contribution to journal › Commentary/debate › peer-review

TY - JOUR

T1 - Erratum

T2 - Paradox-Breaking RAF Inhibitors that Also Target SRC Are Effective in Drug-Resistant BRAF Mutant Melanoma (Cancer Cell (2015) 27(1) (85–96) (S1535610814004577) (10.1016/j.ccell.2014.11.006))

AU - Girotti, Maria Romina

AU - Lopes, Filipa

AU - Preece, Natasha

AU - Niculescu-Duvaz, Dan

AU - Zambon, Alfonso

AU - Davies, Lawrence

AU - Whittaker, Steven

AU - Saturno, Grazia

AU - Viros, Amaya

AU - Pedersen, Malin

AU - Suijkerbuijk, Bart M.J.M.

AU - Menard, Delphine

AU - McLeary, Robert

AU - Johnson, Louise

AU - Fish, Laura

AU - Ejiama, Sarah

AU - Sanchez-Laorden, Berta

AU - Hohloch, Juliane

AU - Carragher, Neil

AU - Macleod, Kenneth

AU - Ashton, Garry

AU - Marusiak, Anna A.

AU - Fusi, Alberto

AU - Brognard, John

AU - Frame, Margaret

AU - Lorigan, Paul

AU - Marais, Richard

AU - Springer, Caroline

PY - 2017/3/13

Y1 - 2017/3/13

N2 - (Cancer Cell 27, 85–96, January 12, 2015) The authors have noted an error in Figure 6A of the originally published version of this article. The image for pERK (top right panel) was incorrectly duplicated from Figure 4E (top right panel). The corrected Figure 6 is shown here. This error does not alter the original conclusions of the study, but the authors wish to apologize for this oversight and any confusion that may have resulted.

AB - (Cancer Cell 27, 85–96, January 12, 2015) The authors have noted an error in Figure 6A of the originally published version of this article. The image for pERK (top right panel) was incorrectly duplicated from Figure 4E (top right panel). The corrected Figure 6 is shown here. This error does not alter the original conclusions of the study, but the authors wish to apologize for this oversight and any confusion that may have resulted.

UR - http://europepmc.org/abstract/med/28292443

U2 - 10.1016/j.ccell.2017.02.007

DO - 10.1016/j.ccell.2017.02.007

M3 - Commentary/debate

C2 - 28292443

AN - SCOPUS:85015077534

SN - 1535-6108

VL - 31

JO - Cancer Cell

JF - Cancer Cell

IS - 3

ER -

Erratum: Paradox-Breaking RAF Inhibitors that Also Target SRC Are Effective in Drug-Resistant BRAF Mutant Melanoma (Cancer Cell (2015) 27(1) (85–96) (S1535610814004577) (10.1016/j.ccell.2014.11.006))

Abstract

Research Beacons, Institutes and Platforms

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this